Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Weldon

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Biology Open|June 9, 2025
Intracellular trafficking of furin enhances cellular intoxication by recombinant immunotoxins based on Pseudomonas exotoxin ABrian D Grossman, Jack D Sanford, Yuyi Zhu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
A recombinant immunotoxin targeting CD22 with low immunogenicity, low nonspecific toxicity, and high antitumor activity in miceJohanna K Hansen, John E Weldon, Laiman Xiang, et al.
Protein Engineering, Design & Selection : PEDS|November 22, 2011
A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicityWenhai Liu, Masanori Onda, Changhoon Kim, et al.
Work (Reading, Mass.)|February 19, 2010
Biomechanical shoulder loads and postures in light automotive assembly workers: Comparison between shoulder pain/no pain groupsF A Seaman, W J Albert, N R E Weldon, et al.
The Journal of Biological Chemistry|August 2, 2001
The gene ygdP, associated with the invasiveness of Escherichia coli K1, designates a Nudix hydrolase, Orf176, active on adenosine (5')-pentaphospho-(5')-adenosine (Ap5A)M J Bessman, J D Walsh, C A Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2011
Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopesMasanori Onda, Richard Beers, Laiman Xiang, et al.
Acta Neuropsychiatrica|March 24, 2023
Has maternal sensitivity been comprehensively investigated in sub-Saharan Africa? A narrative scoping reviewA Prag, K A Donald, E Weldon, et al.
Blood|November 8, 2008
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicityJohn E Weldon, Laiman Xiang, Oleg Chertov, et al.
Acta Cytologica|March 1, 1990
Adenocarcinoma with a neuroendocrine component arising in the urachus. A case reportJ D Hom, E B King, R Fraenkel, et al.
Molecular Cancer Therapeutics|November 9, 2012
A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicityJohn E Weldon, Laiman Xiang, Jingli Zhang, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Biology Open|June 9, 2025
Intracellular trafficking of furin enhances cellular intoxication by recombinant immunotoxins based on Pseudomonas exotoxin ABrian D Grossman, Jack D Sanford, Yuyi Zhu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
A recombinant immunotoxin targeting CD22 with low immunogenicity, low nonspecific toxicity, and high antitumor activity in miceJohanna K Hansen, John E Weldon, Laiman Xiang, et al.
Protein Engineering, Design & Selection : PEDS|November 22, 2011
A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicityWenhai Liu, Masanori Onda, Changhoon Kim, et al.
Work (Reading, Mass.)|February 19, 2010
Biomechanical shoulder loads and postures in light automotive assembly workers: Comparison between shoulder pain/no pain groupsF A Seaman, W J Albert, N R E Weldon, et al.
The Journal of Biological Chemistry|August 2, 2001
The gene ygdP, associated with the invasiveness of Escherichia coli K1, designates a Nudix hydrolase, Orf176, active on adenosine (5')-pentaphospho-(5')-adenosine (Ap5A)M J Bessman, J D Walsh, C A Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2011
Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopesMasanori Onda, Richard Beers, Laiman Xiang, et al.
Acta Neuropsychiatrica|March 24, 2023
Has maternal sensitivity been comprehensively investigated in sub-Saharan Africa? A narrative scoping reviewA Prag, K A Donald, E Weldon, et al.
Blood|November 8, 2008
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicityJohn E Weldon, Laiman Xiang, Oleg Chertov, et al.
Acta Cytologica|March 1, 1990
Adenocarcinoma with a neuroendocrine component arising in the urachus. A case reportJ D Hom, E B King, R Fraenkel, et al.
Molecular Cancer Therapeutics|November 9, 2012
A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicityJohn E Weldon, Laiman Xiang, Jingli Zhang, et al.
Pageof 5